We compared the four vaccines and observed that the F3 formulation determined a significant enhancement of frequencies of CD4+ and CD8+ secreting-T cells after immunization (Figures 7, 9), while the chimera vaccine was predominant for both types of T cells after infection (Figures 11, 13). The gene discussed is CD8A; the disease is infection.